{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-004019","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.726078+00:00","generated_at":"2026-06-13T20:03:13.005697+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Corvus Pharmaceuticals holds 2023 annual meeting; elects directors and ratifies auditor","bullets":["Stockholders elected Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D. as Class I directors for three-year terms.","Ratified PricewaterhouseCoopers as independent auditor for FY2023 with 35.9M votes for, 0.1M against.","Non-binding advisory vote on executive compensation passed with 25.6M for, 0.4M against.","Total shares voted: 36.2M of 46.6M outstanding (77.6% turnout)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-004019","json":"https://secwatch.observer/filing/0001171843-23-004019.json","markdown":"https://secwatch.observer/filing/0001171843-23-004019.md","text":"https://secwatch.observer/filing/0001171843-23-004019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/f8k_062023.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:03:13.005697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c9da18d212ba763ad67f13ee2bb388c6092a6eb","claim":"Corvus Pharmaceuticals, Inc. shareholders approved Non-binding advisory vote to approve compensation of named executive officers at the 2023-06-15 meeting.","evidence_excerpt":"Votes For Votes Against Abstain Broker Non-Votes 25,550,695 348,929 177,941 10,073,471","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"7a5542e8a527b7960a79b6d4b4288edc0ea97b9f","claim":"Corvus Pharmaceuticals, Inc. shareholders approved Ratification of selection of PricewaterhouseCoopers LLC as independent registered accounting firm at the 2023-06-15 meeting.","evidence_excerpt":"Votes For Votes Against Abstain 35,873,795 104,973 172,268","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"a351c9096b916533891ba6557720a7788d16faad","claim":"Corvus Pharmaceuticals, Inc. shareholders approved Election of Class I directors at the 2023-06-15 meeting.","evidence_excerpt":"Class I Director Nominees Votes For Votes Withheld Broker Non-Votes Richard A. Miller, M.D. 26,009,538 68,027 10,073,471 Linda S. Grais, M.D. J.D. 25,210,111 867,454 10,073,471","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323004019/0001171843-23-004019-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}